We are live on ! Find out more
CF

C.T. Fitzpatrick Vulcan Value Partners

AUM $3.29B
1-Year Est. Return 6.08%
 

C.T. Fitzpatrick is the founder of Vulcan Value Partners, a firm that seeks high-quality businesses when they trade at discounts to estimated intrinsic value. Vulcan is known for a disciplined appraisal process and a willingness to hold cash when bargains are scarce. The firm’s equities strategies are widely followed in quality-value circles.

This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
-6.08%
3 Year Est. Return
+28.5%
5 Year Est. Return
+25.59%
10 Year Est. Return
+233.17%
AUM
$11.2B
AUM Growth
+$339M
Cap. Flow
-$217M
Cap. Flow %
-1.93%
Top 10 Hldgs %
44.36%
Holding
67
New
9
Increased
16
Reduced
29
Closed
13

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$432M
2
CAH icon
Cardinal Health
CAH
+$313M
3
COR icon
Cencora
COR
+$304M
4
MCK icon
McKesson
MCK
+$261M
5
CBRE icon
CBRE Group
CBRE
+$217M

Top Sells

Rank Stock Value
1
BEN icon
Franklin Templeton, Inc.
BEN
+$329M
2
PH icon
Parker-Hannifin
PH
+$252M
3
TROW icon
T. Rowe Price
TROW
+$161M
4
BA icon
Boeing
BA
+$149M
5
RTX icon
RTX Corp
RTX
+$147M

Sector Composition

Rank Sector Weight
1 Financials 27.88%
2 Healthcare 19.41%
3 Technology 18.48%
4 Consumer Discretionary 10.7%
5 Industrials 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
1
Oracle
ORCL
$422B
$870M 7.75%
22,633,884
+299,598
+1% +$11.7M
NOV icon
2
NOV
NOV
$7.28B
$610M 5.43%
16,295,053
-2,053,756
-11% -$74.8M
AXS icon
3
AXIS Capital
AXS
$7.2B
$518M 4.62%
7,943,351
-409,043
-5% -$24.6M
MCK icon
4
McKesson
MCK
$100B
$486M 4.33%
3,461,194
+1,775,467
+105% +$261M
ELV icon
5
Elevance Health
ELV
$86.9B
$439M 3.91%
3,050,319
-111,728
-4% -$15M
EG icon
6
Everest Group
EG
$14.2B
$429M 3.82%
1,981,260
-88,158
-4% -$18.2M
COR icon
7
Cencora
COR
$60.7B
$425M 3.79%
5,440,860
+3,892,674
+251% +$304M
CVS icon
8
CVS Health
CVS
$119B
$421M 3.75%
+5,334,307
New +$432M
MA icon
9
Mastercard
MA
$509B
$395M 3.52%
3,823,683
-94,704
-2% -$9.8M
DISCK
10
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$386M 3.44%
14,410,942
-379,005
-3% -$9.99M
STT icon
11
State Street
STT
$51.4B
$378M 3.37%
4,865,592
-339,767
-7% -$25.6M
V icon
12
Visa
V
$693B
$378M 3.36%
4,839,570
+79,656
+2% +$6.4M
HLT icon
13
Hilton Worldwide
HLT
$73.5B
$363M 3.23%
4,450,234
-165,410
-4% -$12.2M
CAH icon
14
Cardinal Health
CAH
$53.4B
$312M 2.78%
+4,332,718
New +$313M
QRVO icon
15
Qorvo
QRVO
$8.43B
$306M 2.73%
5,803,082
+1,001,936
+21% +$54.5M
SWKS icon
16
Skyworks Solutions
SWKS
$10.1B
$297M 2.64%
3,972,476
-1,051,612
-21% -$81M
FOSL icon
17
Fossil Group
FOSL
$332M
$294M 2.62%
11,369,693
-114,629
-1% -$3.45M
BA icon
18
Boeing
BA
$169B
$290M 2.58%
1,860,523
-1,022,346
-35% -$149M
BNY
19
Bank of New York Mellon
BNY
$108B
$280M 2.5%
5,913,757
-3,077,218
-34% -$139M
CBRE icon
20
CBRE Group
CBRE
$44B
$236M 2.11%
+7,509,946
New +$217M
DIS icon
21
Walt Disney
DIS
$186B
$227M 2.02%
2,177,854
-33,049
-1% -$3.22M
BEN icon
22
Franklin Templeton, Inc.
BEN
$17.4B
$214M 1.9%
5,400,910
-8,789,020
-62% -$329M
IHG icon
23
InterContinental Hotels
IHG
$23.6B
$199M 1.78%
+4,090,716
New +$185M
CSCO icon
24
Cisco
CSCO
$438B
$177M 1.58%
5,871,339
-748,318
-11% -$22.8M
AET
25
DELISTED
Aetna Inc
AET
$173M 1.54%
1,394,753
-77,493
-5% -$9.28M
1
2 3

Similar funds

BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OCM
Oribel Capital Management New York $3.29B AUM 83.82% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.3B AUM 0.25% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

C.T. Fitzpatrick's Q4 2016 Portfolio in Review

As of Q4 2016, C.T. Fitzpatrick held 67 positions worth $11.2B, up 3.1% from $10.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

C.T. Fitzpatrick's Q4 2016 filing shows 9 new, 16 increased, 29 reduced and 13 closed positions. Its largest new stake was CVS Health: 5,334,307 shares worth $421M. The largest sale was Franklin Templeton, Inc., an estimated $329M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 33% a quarter earlier, followed by Healthcare and Technology.

  • C.T. Fitzpatrick's largest Q4 2016 buy was CVS Health: 5,334,307 shares worth $421M.
  • C.T. Fitzpatrick added most to Cencora in Q4 2016, an estimated $304M increase.
  • C.T. Fitzpatrick's biggest Q4 2016 reduction was Franklin Templeton, Inc., cutting an estimated $329M.
  • C.T. Fitzpatrick fully exited T. Rowe Price in Q4 2016, selling an estimated $161M.
  • C.T. Fitzpatrick's ten largest holdings make up 44% of its $11.2B portfolio in Q4 2016.
  • C.T. Fitzpatrick opened 9 new positions and closed 13 in Q4 2016.
  • C.T. Fitzpatrick's portfolio value rose 3.1% quarter-over-quarter to $11.2B.

Based on Vulcan Value Partners's 13F filing for Q4 2016, filed 14 Feb 2017.